265 related articles for article (PubMed ID: 9693183)
1. Classic Kaposi's sarcoma: low-dose interferon alfa treatment.
Tur E; Brenner S
Dermatology; 1998; 197(1):37-42. PubMed ID: 9693183
[TBL] [Abstract][Full Text] [Related]
2. Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma.
Tur E; Brenner S; Michalevicz R
Arch Dermatol; 1993 Oct; 129(10):1297-300. PubMed ID: 8215494
[TBL] [Abstract][Full Text] [Related]
3. Non-human immunodeficiency virus Kaposi's sarcoma can be effectively treated with low-dose interferon-alpha despite the persistence of herpesvirus-8.
Deichmann M; Thome M; Jäckel A; Utermann S; Bock M; Waldmann V; Näher H
Br J Dermatol; 1998 Dec; 139(6):1052-4. PubMed ID: 9990371
[TBL] [Abstract][Full Text] [Related]
4. Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.
Kreuter A; Rasokat H; Klouche M; Esser S; Bader A; Gambichler T; Altmeyer P; Brockmeyer NH
Cancer Invest; 2005; 23(8):653-9. PubMed ID: 16377582
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b.
Costa da Cunha CS; Lebbe C; Rybojad M; Agbalika F; Ferchal F; Rabian C; Vignon-Pennamen MD; Calvo F; Morel P
Arch Dermatol; 1996 Mar; 132(3):285-90. PubMed ID: 8607632
[TBL] [Abstract][Full Text] [Related]
6. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
Volkow P; Zinser JW; Correa-Rotter R
BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.
Gill PS; McLaughlin T; Espina BM; Tulpule A; Louie S; Lunardi-Iskandar Y; Gallo RC
J Natl Cancer Inst; 1997 Dec; 89(23):1797-802. PubMed ID: 9392621
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract][Full Text] [Related]
9. Classic Kaposi's sarcoma treated with topical 0.5% timolol gel.
Alcántara-Reifs CM; Salido-Vallejo R; Garnacho-Saucedo GM; Vélez García-Nieto A
Dermatol Ther; 2016 Sep; 29(5):309-311. PubMed ID: 27329079
[No Abstract] [Full Text] [Related]
10. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.
Shepherd FA; Beaulieu R; Gelmon K; Thuot CA; Sawka C; Read S; Singer J
J Clin Oncol; 1998 May; 16(5):1736-42. PubMed ID: 9586886
[TBL] [Abstract][Full Text] [Related]
11. Treatment of classical type Kaposi's sarcoma with paclitaxel.
Chao SC; Lee JY; Tsao CJ
Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
[TBL] [Abstract][Full Text] [Related]
12. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA.
Saiag P; Pavlovic M; Clerici T; Feauveau V; Nicolas JC; Emile D; Chastang C
AIDS; 1998 Nov; 12(16):2169-76. PubMed ID: 9833858
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
[TBL] [Abstract][Full Text] [Related]
14. [Kaposi's sarcoma treated with topical alitretinoin].
González de Arriba A; Pérez-Gala S; Goiriz-Valdés R; Ríos-Buceta L; García-Díez A
Actas Dermosifiliogr; 2007; 98(1):50-3. PubMed ID: 17374335
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic effect of intralesional interferon in classical Kaposi's sarcoma.
Trattner A; Reizis Z; David M; Ingber A; Hagler J; Sandbank M
Br J Dermatol; 1993 Nov; 129(5):590-3. PubMed ID: 8251357
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS; Rarick MU; Bernstein-Singer M; Espina BM; Jones B; Montgomery T; Sharma D; Rasheed S; Levine AM
J Biol Response Mod; 1990 Oct; 9(5):512-6. PubMed ID: 2254762
[TBL] [Abstract][Full Text] [Related]
17. Classic Kaposi's sarcoma in two young heterosexual men.
Potouridou I; Katsambas A; Pantazi V; Armenaka M; Stavrianeas N; Stratigos J
J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):48-52. PubMed ID: 9552757
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
[TBL] [Abstract][Full Text] [Related]
19. [The value of conventionally fractionated radiotherapy in the local treatment of HIV-related Kaposi's sarcoma].
Saran F; Adamietz IA; Mose S; Thilmann C; Böttcher HD
Strahlenther Onkol; 1995 Oct; 171(10):594-9. PubMed ID: 8571179
[TBL] [Abstract][Full Text] [Related]
20. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
Dezube BJ
Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
